Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Off-label use of chloroquine, hydroxychloroquine, azithromycin and lopinavir/ritonavir in COVID-19 risks prolonging the QT interval by targeting the hERG channel
Authors
Keywords
COVID-19, Drugs, hERG channel, QT interval, Long QT syndrome (LQTS)
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 893, Issue -, Pages 173813
Publisher
Elsevier BV
Online
2020-12-18
DOI
10.1016/j.ejphar.2020.173813
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- (2020) Manli Wang et al. CELL RESEARCH
- COVID-19 and the cardiovascular system
- (2020) Ying-Ying Zheng et al. Nature Reviews Cardiology
- An Update on the Structure of hERG
- (2020) Andrew Butler et al. Frontiers in Pharmacology
- Modulation of hERG K+ Channel Deactivation by Voltage Sensor Relaxation
- (2020) Yu Patrick Shi et al. Frontiers in Pharmacology
- Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
- (2020) Jinoos Yazdany et al. ANNALS OF INTERNAL MEDICINE
- Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society
- (2020) John L. Sapp et al. CANADIAN JOURNAL OF CARDIOLOGY
- Safety considerations with chloroquine, hydroxychloroquine and azithromycin in the management of SARS-CoV-2 infection
- (2020) David N. Juurlink CANADIAN MEDICAL ASSOCIATION JOURNAL
- The Effect of Chloroquine, Hydroxychloroquine and Azithromycin on the Corrected QT Interval in Patients with SARS-CoV-2 Infection
- (2020) Moussa Saleh et al. Circulation-Arrhythmia and Electrophysiology
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Chloroquine for COVID-19 Infection
- (2020) Nicholas Moore DRUG SAFETY
- Chloroquine-induced torsades de pointes in a patient with coronavirus disease 2019
- (2020) Yishay Szekely et al. HEART RHYTHM
- SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes
- (2020) Cheng-I. Wu et al. HEART RHYTHM
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Chloroquine hype is derailing the search for coronavirus treatments
- (2020) Heidi Ledford NATURE
- Potential of chloroquine and hydroxychloroquine to treat COVID-19 causes fears of shortages among people with systemic lupus erythematosus
- (2020) Deepak Jakhar et al. NATURE MEDICINE
- The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin
- (2020) Ehud Chorin et al. NATURE MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Race to find COVID-19 treatments accelerates
- (2020) Kai Kupferschmidt et al. SCIENCE
- Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
- (2020) Nathan Ford et al. Journal of the International AIDS Society
- Chloroquine and hydroxychloroquine in covid-19
- (2020) Robin E Ferner et al. BMJ-British Medical Journal
- The EAG Voltage-Dependent K+ Channel Subfamily: Similarities and Differences in Structural Organization and Gating
- (2020) Francisco Barros et al. Frontiers in Pharmacology
- Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Nicholas J. Mercuro et al. JAMA Cardiology
- Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19)
- (2020) Riccardo M. Inciardi et al. JAMA Cardiology
- Cardiac safety of off-label COVID-19 drug therapy: a review and proposed monitoring protocol
- (2020) Niyada Naksuk et al. European Heart Journal-Acute Cardiovascular Care
- Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)
- (2020) John R. Giudicessi et al. MAYO CLINIC PROCEEDINGS
- Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- A pharmacological master key mechanism that unlocks the selectivity filter gate in K+ channels
- (2019) Marcus Schewe et al. SCIENCE
- Intracellular Mechanism of Rosuvastatin-Induced Decrease in Mature hERG Protein Expression on Membrane
- (2019) Pan-Feng Feng et al. MOLECULAR PHARMACEUTICS
- From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2
- (2019) Peter J Schwartz et al. EUROPEAN HEART JOURNAL
- RRAD mutation causes electrical and cytoskeletal defects in cardiomyocytes derived from a familial case of Brugada syndrome
- (2019) Nadjet Belbachir et al. EUROPEAN HEART JOURNAL
- The Potential for QT Interval Prolongation with Chronic Azithromycin Therapy in Adult Cystic Fibrosis Patients
- (2019) Sean N. Avedissian et al. PHARMACOTHERAPY
- Complex aberrant splicing in the induced pluripotent stem cell–derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1 -A344Aspl mutation
- (2018) Yimin Wuriyanghai et al. HEART RHYTHM
- Structural implications of hERG K+channel block by a high-affinity minimally structured blocker
- (2018) Matthew V. Helliwell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of the unfolded protein response downregulates cardiac ion channels in human induced pluripotent stem cell-derived cardiomyocytes
- (2018) Man Liu et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Comprehensive review of cardiovascular toxicity of drugs and related agents
- (2018) Přemysl Mladěnka et al. MEDICINAL RESEARCH REVIEWS
- The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins
- (2018) Panfeng Feng et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review
- (2018) Ilsa L. Haeusler et al. BMC Medicine
- Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model
- (2017) Ashish Mehta et al. EUROPEAN HEART JOURNAL
- Towards a Structural View of Drug Binding to hERG K + Channels
- (2017) Jamie I. Vandenberg et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform
- (2016) Chris Denning et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- A new hERG allosteric modulator rescues genetic and drug‐induced long‐QT syndrome phenotypes in cardiomyocytes from isogenic pairs of patient induced pluripotent stem cells
- (2016) Luca Sala et al. EMBO Molecular Medicine
- Predicting the Unpredictable
- (2016) Peter J. Schwartz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Structure of the voltage-gated K+ channel Eag1 reveals an alternative voltage sensing mechanism
- (2016) J. R. Whicher et al. SCIENCE
- Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias
- (2016) Ksenia Blinova et al. TOXICOLOGICAL SCIENCES
- New potential binding determinant for hERG channel inhibitors
- (2016) P. Saxena et al. Scientific Reports
- The protease inhibitor atazanavir blocks hERG K+ channels expressed in HEK293 cells and obstructs hERG protein transport to cell membrane
- (2015) Sheng-na Han et al. ACTA PHARMACOLOGICA SINICA
- The enhancement of cardiac toxicity by concomitant administration of Berberine and macrolides
- (2015) Duo Zhi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?
- (2015) Christiaan C. Veerman et al. STEM CELLS AND DEVELOPMENT
- Macrolide Antibiotics and the Risk of Cardiac Arrhythmias
- (2014) Richard K. Albert et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- hERG trafficking inhibition in drug-induced lethal cardiac arrhythmia
- (2014) Hisashi Nogawa et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Availability of human induced pluripotent stem cell-derived cardiomyocytes in assessment of drug potential for QT prolongation
- (2014) Yumiko Nozaki et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy
- (2013) P. J. Schwartz et al. EUROPEAN HEART JOURNAL
- Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study
- (2013) Alejandro Llanos-Cuentas et al. LANCET
- In VitroCardiovascular Effects of Dihydroartemisin-Piperaquine Combination Compared with Other Antimalarials
- (2012) Franco Borsini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Disease characterization using LQTS-specific induced pluripotent stem cells
- (2012) Toru Egashira et al. CARDIOVASCULAR RESEARCH
- Azithromycin and the Risk of Cardiovascular Death
- (2012) Wayne A. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- hERG K+ Channels: Structure, Function, and Clinical Significance
- (2012) Jamie I. Vandenberg et al. PHYSIOLOGICAL REVIEWS
- Cytoplasmic Domains and Voltage-Dependent Potassium Channel Gating
- (2012) Francisco Barros et al. Frontiers in Pharmacology
- High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
- (2011) Junyi Ma et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Antidepressant-induced Ubiquitination and Degradation of the Cardiac Potassium Channel hERG
- (2011) Adrienne T. Dennis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Modelling the long QT syndrome with induced pluripotent stem cells
- (2011) Ilanit Itzhaki et al. NATURE
- Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations
- (2010) Elsayed Z Soliman et al. AIDS
- Drug- and non-drug-associated QT interval prolongation
- (2010) Charlotte Van Noord et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Fluconazole inhibits hERG K+ channel by direct block and disruption of protein trafficking
- (2010) Shengna Han et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Mapping the sequence of conformational changes underlying selectivity filter gating in the Kv11.1 potassium channel
- (2010) David T Wang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Drug-Induced Long QT Syndrome
- (2010) P. Kannankeril et al. PHARMACOLOGICAL REVIEWS
- HIV Protease Inhibitors Induce Endoplasmic Reticulum Stress and Disrupt Barrier Integrity in Intestinal Epithelial Cells
- (2009) Xudong Wu et al. GASTROENTEROLOGY
- Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION® long QT syndrome genetic test
- (2009) Jamie D. Kapplinger et al. HEART RHYTHM
- Ritonavir‐Boosted Atazanavir, Methadone, and Ventricular Tachycardia: 2 Case Reports
- (2008) David P. Gallagher et al. CLINICAL INFECTIOUS DISEASES
- Coexistence of hERG current block and disruption of protein trafficking in ketoconazole-induced long QT syndrome
- (2007) H Takemasa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine
- (2007) Philippe Stas et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic-AV block
- (2006) M B Thomsen et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started